Tonix Pharmaceuticals stock halted ahead of FDA approval news
Investing.com - Wells Fargo initiated coverage on Ternium S.A. (NYSE:TX) with an Underweight rating and a $30.00 price target on Thursday. According to InvestingPro data, the steel producer currently trades at a P/E ratio of 10.8x and offers a substantial dividend yield of 10.9%.
The investment bank set its price target based on a 6x 2026E EV/EBITDA multiple, which stands well above Ternium’s historical average of 4x, while assuming half of the company’s reported provisions. InvestingPro’s analysis suggests the stock is currently overvalued relative to its Fair Value, aligning with Wells Fargo’s cautious stance.
Wells Fargo noted that Ternium’s recent higher trading multiple "assumes too much rebound in earnings," adding that they are "not convinced of a quick fix to tariffs and challenging demand."
The firm acknowledged that Ternium’s heavy recent capital expenditures could boost through-cycle results for the Americas steel producer.
These improvements, however, are likely not expected until 2027E/28E, according to Wells Fargo’s analysis.
In other recent news, Ternium S.A. reported its second-quarter results for 2025, showing a significant earnings performance. The company’s adjusted earnings per ADS reached $1.28, which nearly doubled the analyst expectations of $0.65. However, revenue came in slightly below projections at $3.95 billion, compared to the consensus estimate of $4 billion, marking a 13% decrease from the $4.51 billion reported in the same quarter last year. Despite the revenue shortfall, Ternium’s Adjusted EBITDA margin showed improvement, rising to 10% from 8% in the previous quarter. These developments come amid challenging market conditions for the Luxembourg-based steel producer. The earnings beat has drawn attention from investors and analysts alike. The positive earnings report may influence future analyst assessments, though no specific upgrades or downgrades were mentioned. These updates provide a glimpse into Ternium’s current financial standing and strategic direction.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.